Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution (Q44517700)

3 December 2017

title

Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution (English)

1 reference

People's Republic of China

3 December 2017

main subject

0 references

author name string

Pei Yang

1 reference

3 December 2017

Yongzhi Wang

1 reference

3 December 2017

Xiaoxia Peng

1 reference

3 December 2017

Gan You

1 reference

3 December 2017

Wei Zhang

1 reference

3 December 2017

Wei Yan

1 reference

3 December 2017

Zhaoshi Bao

1 reference

3 December 2017

Yinyan Wang

1 reference

3 December 2017

Xiaoguang Qiu

1 reference

3 December 2017

Tao Jiang

1 reference

3 December 2017

publication date

13 March 2013

1 reference

Journal of Neuro-Oncology

3 December 2017

published in

1 reference

3 December 2017

volume

113

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

259-266

1 reference

Epidemiology and etiology of gliomas

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Patterns of care for adults with newly diagnosed malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

2007 World Health Organization classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Immunohistochemical markers for prognosis of cerebral glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Clinical and radiological prognostic factors of anaplastic oligodendroglioma treated by combined therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

High -catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Extent of resection in malignant gliomas: a critical summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Glioblastoma--a moving target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

GFAP, Ki67 and IDH1: perhaps the golden triad of glioma immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Relative survival of patients with supratentorial low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1103-9

Multivariate analysis of prognostic factors and survival in patients with "glioblastoma multiforme"

21 January 2018

1 reference

12 December 2020

Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up

1 reference

12 December 2020

Head and neck cancers

1 reference

12 December 2020

World Health Organization classification of tumors

1 reference

12 December 2020

Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme.

1 reference

12 December 2020

The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.

1 reference

12 December 2020

10.1007/S11060-013-1103-9

Identifiers

DOI

1 reference

3 December 2017

1 reference